It's Thursday which means it's the second night of the week to win big on the National Lottery's Set For Life game. By entering tonight's Set for Life draw, you could be a few numbers away from ...

Bibhash is an investment fund manager, investor, company builder and board member with almost 2 decades of experience in biotech. He is the CEO of Sapient Biotech, which is currently building a sector ...

A new study released by the Massachusetts Institute of Technology revealed that artificial intelligence can already replace 11.7% of the U.S. labor market, potentially impacting $1.2 trillion in wages ...

Palantir CEO Alex Karp attributed Zohran Mamdani’s election as New York mayor to a reverse class warfare: “I think the average Ivy League grad voting for this mayor is highly annoyed that their ...

In the modern landscape of personalized diagnostics, drug research, development, and manufacturing, data integrity and velocity of the product-to-market are everything. A key player driving the ...

AMERICA’s BODY corporate looks, as a whole, to be in rude health. One large company after another is presenting record quarterly results. Bosses are raising profit forecasts left and right. Poke and ...

We used to say data is the new oil. In commercial life sciences, context has become oxygen. AI can read millions of pages, extract structure from chaos and turn scattered trial data, clinical notes ...

A US school assignment went viral for all the wrong reasons this week — quizzing fifth-grade students on the life and work of Charlie Kirk. The right-wing activist was shot dead last month during a ...

Understand the fundamentals that drive life. Do basic research that leads to medical breakthroughs and improvements in our world. Study the underlying chemistry of organisms and ecosystems. Help ...

The new year promises to deliver a fresh array of plans and obligations, on top of all the challenges carried over from the year past. But there's hope: These expert-generated tips can help you ...

The number of scientific papers flagged as fraudulent has been growing. Now a new paper sheds light on how it’s being done. Researchers found loose networks of unscrupulous editors working with ...

Frazier Life Sciences has gathered an impressive $1.3 billion in capital commitments for its 12th venture fund aimed at private early-stage biotechs. The Palo Alto-based firm said it has now raised ...